BAYZF - Recursion Pharma spikes after licensing deal with Bayer
2024-01-04 15:25:59 ET
More on Recursion Pharmaceuticals
- Recursion Pharmaceuticals: Second Half 2024 Data Readouts Are Major Inflection Points
- Absci hits new 52-week high as race for AI drug discovery heats up
- Recursion Pharma spikes after 3.8M ARK buy
- Seeking Alpha’s Quant Rating on Recursion Pharmaceuticals
- Historical earnings data for Recursion Pharmaceuticals
For further details see:
Recursion Pharma spikes after licensing deal with Bayer